Cite
MLA Citation
Yulia Vugmeyster et al.. “Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1.” Clinical pharmacology & therapeutics, vol. 108, no. 3, 2020, pp. 566–574. http://access.bl.uk/ark:/81055/vdc_100106635569.0x00005b